A randomised controlled clinical feasibility trial to determine the feasibility and acceptability of a "musculoskeletal health package (MHP)" intervention in women undergoing pelvic radiotherapy for gynaecological malignancies and inform power calculations for a definitive trial.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Eligibility and screening rate
Timeframe: baseline
Recruitment and study group allocation rate
Timeframe: 2 weeks post consent
Recruitment and study group allocation rate
Timeframe: 2 weeks post consent
Intervention fidelity rate
Timeframe: end of study 18 months
Intervention fidelity rate
Timeframe: end of study 18 months
Attrition rate
Timeframe: end of study 18 months
Patient and physician acceptability y
Timeframe: change from baseline to 6 months
Patient and physician acceptability y
Timeframe: change from baseline to 12 months
Patient and physician acceptability y
Timeframe: change from baseline to 18 months
Health Economic QOL Analysis
Timeframe: change from baseline to 6 months
Health Economic QOL Analysis
Timeframe: change from baseline to 12 months
Health Economic QOL Analysis
Timeframe: change from baseline to 18 months